This site is intended for healthcare professionals
  • Home
  • /
  • Clinical trials
  • /
  • Uncategorised Disease
  • /
  • p53-Adjusted Neoadjuvant Chemotherapy for potentia...
Clinical trial

p53-Adjusted Neoadjuvant Chemotherapy for potentially resectable Oesophageal Cancer "pANCHO".

Read time: 1 mins
Last updated:16th May 2007
The objective of this prospective randomized predictive marker study is to evaluate the interaction between a predictive marker and response to induction chemotherapy in patients with potentially resectable esophageal cancer. This study is designed to demonstrate the significant interaction of the two p53 genotypes (mutant versus normal) and response to 2 different neoadjuvant chemotherapies.
Category Value
Study start date 2007-05-16

View full details